Filing Details
- Accession Number:
- 0001209191-20-011830
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-21 20:07:16
- Reporting Period:
- 2020-02-19
- Accepted Time:
- 2020-02-21 20:07:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1349376 | P Timothy Walbert | C/O Horizon Therapeutics Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-02-19 | 48,432 | $0.00 | 963,064 | No | 4 | A | Direct | |
| Ordinary Shares | Disposition | 2020-02-19 | 21,457 | $36.06 | 941,607 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2020-02-21 | 93,864 | $35.23 | 847,743 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Performance Restricted Stock Units (PSUs) | Acquisiton | 2020-02-19 | 96,864 | $0.00 | 96,864 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 96,864 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 9,150 | Indirect | By spouse |
Footnotes
- On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above. The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022.
- The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on May 23, 2019.
- Each PSU represents a contingent right to receive one ordinary share of the Issuer.
Billionaire Hedge Funds
